Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

EGF Theramed Health Corp. (C:TMED)

Business Focus: Biotechnology & Medical Research (NEC)

Feb 08, 2023 04:05 pm ET
EGF Theramed Has Signed Its First Non-Binding LOI to Aquire Its First Cannabis Dispensary
Vancouver, British Columbia--(Newsfile Corp. - February 8, 2023) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUH) (the "Company" of "EGF") is pleased to announce it has progressed forward and is now very close to acquiring various dispensary targets in British Columbia. Having looked at targets throughout Canada for the last few months, the market has become increasingly favorable to acquire assets from distressed single store operators favoring scaled centralized operations. Many single store operators that gained an early mover advantage have felt the effects COVID to their bottom line giving EGF an advantage in its acquisitions.
Nov 02, 2022 04:02 pm ET
EGF Theramed Looking to Acquire Retail Cannabis Assets
Vancouver, British Columbia--(Newsfile Corp. - November 2, 2022) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUHP) (the "Company" of "EGF") has begun to look into the acquisition of overleveraged retail cannabis assets across Canada and the United States. The ideal target asset will be cash flow positive dispensaries that are located in densely populated areas with high demand for adult recreational cannabis use. As the market has become ever competitive many dispensaries have become leveraged presenting ideal acquisition targets that can be obtained at a fraction of their true value and potential.
Sep 14, 2022 04:02 pm ET
EGF Theramed Secures $10 Million Term Sheet Agreement
Vancouver, British Columbia--(Newsfile Corp. - September 14, 2022) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUHP) (the "Company" of "EGF") has secured a term sheet agreement with Reef Capital, pursuant to which the lender will loan up to $10-million to EGF Theramed in ten tranches of $500,000.00 each. The Company may use any and all proceeds raised pursuant to the issuance of the Notes for acquisitions, working capital, and general corporate purposes, as determined by the Company's Board of Directors and its senior executive management team.
Aug 18, 2022 04:05 pm ET
EGF Theramed Announces New CEO and Business Expansion Plan
Vancouver, British Columbia--(Newsfile Corp. - August 18, 2022) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUHP) (the "Company" of "EGF") is pleased to announce Connor Yuen as its new Chief Executive Officer. Mr. Connor Yuen is the founder and Chief Investment Officer of Conquest Capital, a Vancouver based private equity fund. He has successfully managed this fund in both public and private markets. Mr Yuen has excelled in his previous experience as a CEO and sits on the board of directors of numerous companies that have achieved market capitalizations of over $100M CAD.
Jul 07, 2022 04:43 pm ET
CSE Bulletin: Consolidation - EGF Theramed Health Corp. (TMED)
Toronto, Ontario--(Newsfile Corp. - le 7 juillet/July 2022) - EGF Theramed Health Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty (20) pre-consolidated common shares.
Jun 25, 2021 04:05 pm ET
EGF Theramed Joint Venture Partner Pharmadelic Labs Announces Lab Services Agreement With Numinus Wellness
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2021) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) ("Theramed", the "Company") is pleased to announce that its subsidiary joint venture Pharmadelic Labs Inc. ("Pharmadelic") has signed a laboratory services agreement with Numinus Wellness Inc. (TSXV: NUMI) ("Numinus").
Jan 19, 2021 09:10 pm ET
EGF Theramed Completes Private Placement and Raises $528,502
VANCOUVER, BC / ACCESSWIRE / January 19, 2021 / EGF Theramed Health Corp. (CSE:TMED)(OTC PINK:EVAHF) (the "Company") is pleased to announce that it has completed the second and final tranche of its previously announced (December 10, 2020 and December 15, 2021) offering (the "Offering"), issuing 1,466,666 units (each a "Unit") by way of non-brokered private placement at a price of $0.12 per Unit for gross proceeds of $175,999.92. Each Unit consists of one common share of the Company and one half of one common share purchase war
Jan 15, 2021 08:30 am ET
EGF Theramed Raises $352,502 in First Tranche of Private Placement
VANCOUVER, BC / ACCESSWIRE / January 15, 2021 / EGF Theramed Health Corp. (CSE:TMED)(OTCQB:EVAHF) (the "Company") is pleased to announce that it has completed the first tranche of its previously announced (December 10, 2020) offering (the "Offering"), issuing 2,937,516 units (each a "Unit") by way of non-brokered private placement at a price of $0.12 per Unit for gross proceeds of $352,502. Each Unit consists of one common share of the Company and one half of one common share purchase warrant (each, a "Warrant") exercis
Dec 14, 2020 03:55 pm ET
EGF Theramed Signs Agreement to Acquire Seedadelic Med Corp.
VANCOUVER, BC / ACCESSWIRE / December 14, 2020 / EGF Theramed Health Corp. (CSE:TMED)(OTCQB:EVAHF)(FSE:AUHP) (the "Company") is pleased to announce that the Company has entered into a letter of intent dated as of December 14, 2020 to acquire all of the issued and outstanding shares of Seedadelic Med Corp. ("Seedadelic"), a private Ontario corporation) in exchange for the issuance of 15,000,000 common shares of the Company at a deemed price of $0.115 per common share to Seedadelic shareholders (the "Proposed Transaction").
Dec 14, 2020 03:17 pm ET
IIROC Trade Resumption - TMED
VANCOUVER, BC, Dec. 14, 2020 /CNW/ - Trading resumes in:
Dec 14, 2020 03:12 pm ET
IIROC Trading Halt - TMED
VANCOUVER, BC, Dec. 14, 2020 /CNW/ - The following issues have been halted by IIROC:
Dec 10, 2020 06:10 pm ET
EGF Theramed Health Corp. Announces $500,040 Non-Brokered Private Placement
VANCOUVER, BC / ACCESSWIRE / December 10, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF)(FRA:AUHP) (the "Company") is pleased to announce a non-brokered private placement (the "Offering") financing of up to 4,167,000 units (the "Units") of the Company at a price of $0.12 per Unit for gross proceeds of $500,040. Each Unit consists of one common share and one-half of one common share purchase warrant, with each whole warrant entitling the holder to acquire an additional common share of the Company at a price of $0.20 for
Jul 20, 2020 08:30 pm ET
EGF THERAMED HEALTH Provides Update on Pharmadelic Labs and Green Parrot Labs
VANCOUVER, BC / ACCESSWIRE / July 20, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF)(FRA:AUHP) (the "Company") announces that it will rely on the temporary relief granted pursuant to British Columbia Instrument 51-517 (Temporary Exemption from Certain Corporate Finance Requirements with Deadlines during the Period from June 2 to August 31, 2020) in respect of the filing of business acquisition reports ("BAR") for its acquisition of a 30% equity interest in Pharmadelic Labs Corp. ("Pharmadelic") on May 6, 2020 and its acquisit
Jul 09, 2020 08:30 am ET
EGF Theramed Health Announces MOU with Greenfield Global Projects and Joint Venture Partner Green Parrot
VANCOUVER, BC / ACCESSWIRE / July 9, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC PINK:EVAHF)(FRANKFURT:AUHP) (the "Company") announces that Global Green Parrot Laboratories Inc. ("GGP") has entered into a Memorandum of Understanding ("MOU") with Greenfield Global Projects Inc. ("Greenfield"). Greenfield is a private company with extensive cannabis related projects in Jamaica and corporate offices in Vancouver, B.C. Green Parrot Labs Corp. ("Green Parrot"), a joint v
Jun 22, 2020 10:40 am ET
EGF Theramed Health Announces Leased Facilities for Pharmadelic Labs
VANCOUVER, BC / ACCESSWIRE / June 22, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC PINK:EVAHF)(FRANKFURT:AUHP) (the "Company") announces that its joint venture partner, Pharmadelic Labs Corp. ("Pharmadelic Labs"), in which the Company holds a 30% equity interest, has secured additional lab facility space in order to expand its research and development of proprietary processes to help create pharmaceutical grade psilocybin-derived ingredients in a synthetic lab environment.
Jun 10, 2020 05:00 pm ET
EGF Theramed Health Amends Financing
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Jun 02, 2020 07:00 pm ET
EGF Theramed Health Comments Further on Recent Market Activity at the Request of OTC Markets
VANCOUVER, BC / ACCESSWIRE / June 2, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF)(FRA:AUHP) (the "Company").
May 27, 2020 11:45 pm ET
EGF Theramed Health Announces Early Stage Due Diligence On Cash-Generating Psilocybin Assets/Clinics
VANCOUVER, BC / ACCESSWIRE / May 27, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC PINK:EVAHF)(FRA:AUHP)(the "Company") announces that it has commenced due diligence and research into additional acquisition opportunities that complement its current work in the health sciences sector. Specifically, the Company is further investigating the psilocybin and ketamine sectors, focusing on innovative care and specific dose treatments, with the overall goal of improving health and promoting human condition.
May 26, 2020 09:00 am ET
EGF Theramed Health Closes Joint Venture with Acquisition of 40% Interest in Biosynthesis and Wellness Company, Green Parrot Labs
VANCOUVER, BC / ACCESSWIRE / May 26, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC PINK:EVAHF)(FRANKFURT:AUHP) (the "Company") is pleased to announce that it closed on the joint venture transaction with Green Parrot Labs Corp. ("Green Parrot"), previously announced on May 22, 2020.
May 25, 2020 12:25 pm ET
EGF Theramed Health Comments Further on Recent Market Activity at the Request of OTC Markets
VANCOUVER, BC / ACCESSWIRE / May 25, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC:EVAHF)(FRANKFURT:AUHP) (the "Company").
May 22, 2020 09:15 am ET
EGF Theramed Health Announces $2 Million Financing and Joint Venture with Acquisition of 40% Interest in Biosynthesis and Wellness Company, Green Parrot Labs
VANCOUVER, BC / ACCESSWIRE / May 22, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED) (OTC PINK:EVAHF) (FRANKFURT:AUHP) (the "Company").
May 19, 2020 07:10 pm ET
EGF Theramed Health Comments on Recent Market Activity
VANCOUVER, BC / ACCESSWIRE / May 19, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF)(FRA:AUHP) (the "Company"). The Company has recently traded higher than normal volumes due to recent marketing materials and activities. The Company had hired Electric Dojo and SC Strategy Consult at the direction of the Company's former CFO. The Company will continue to look at future marketing opportunities and strategic consultants to grow awareness of the Company and its activities.
May 15, 2020 01:30 am ET
EGF Theramed Appoints George Anstey to Board of Directors
VANCOUVER, BC / ACCESSWIRE / May 15, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED / OTCQB:EVAHF / FRANKFURT:AUHP) (the "Company") today announces the appointment of George Anstey, a cannabis industry specialist, to the Company's Board of Directors. Jeff Lipton has stepped down from the board to allow space for this appointment.
May 14, 2020 08:30 am ET
Theramed Announces Further Developments in Pharmadelic Labs Intellectual Property
VANCOUVER, BC / ACCESSWIRE / May 14, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC PINK:EVAHF)(FRANKFURT:AUHP) (the "Company") wishes to announce that Pharmadelic Labs Corp. ("Pharmadelic Labs"), a Nevada biotech company that uses state-of-the-art technology to create biosynthesis pathways for psilocybin, and whom the Company recently acquired a 30% stake in, has begun pursuing intellectual property ("IP") protection in Canada, the USA and other important jurisdictions.
May 06, 2020 08:30 am ET
EGF Theramed Health Closes Joint Venture With Acquisition Of 30% Interest Of Biosynthesis Company, Pharmadelic Labs
VANCOUVER, BC / ACCESSWIRE / May 6, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF) (the "Company") is pleased to announce that it closed on the joint venture transaction with Pharmadelic Labs Corp. ("Pharmadelic Labs"), previously announced on May 4, 2020.
Apr 13, 2020 06:12 pm ET
EGF Theramed Health Corp. Announces $1.7m Non-brokered Private Placement and Early Stage Due Diligence on Psilocybin Assets
Vancouver, British Columbia--(Newsfile Corp. - April 13, 2020) -  EGF Theramed Health Corp. (CSE: TMED) (OTCQB: EVAHF) (the "Company") is pleased to announce a non-brokered private placement (the "Offering") financing of up to 3,400,000 million units (the "Units") of the Company at a price of $0.50 per Unit for gross proceeds of $1,700,000. Each Unit consists of one common share and one common share purchase warrant, with each warrant entitling the holder to acquire an additional common share of the Company at a price of $0.75 for a period of eighteen (18) months from the closing of the Offering. The Company may pay a finder's fee to one or more arm's length parties who introduce the Company to subscribers, in accordance with the policies of the Canadian Securities Exchange.
Apr 03, 2020 08:02 pm ET
EGF Theramed Announces Resignation of Director and President
Vancouver, British Columbia--(Newsfile Corp. - April 3, 2020) - EGF Theramed Health Corp. (CSE: TMED) announces that Mr. Sydney Au has resigned as a director of EGF Theramed Health Corp. and that Mr. Chris Brown has resigned as President of the company and of its subsidiary Western Agri Supply Solutions Corp. Following the resignations, the Company will be doing a full audit of company financials.The company wishes to thank Mr. Au as a founding director and his many years of service for his contributions to the company and wishes him well in his future endeavors.
Feb 05, 2020 01:40 pm ET
EGF Theramed Announces Change of CFO and Director
VANCOUVER, BC / ACCESSWIRE / February 5, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF) (the "Company) has appointed Usama Chaudhry as CFO and Director of the company. Mr. Chaudhry is an experienced businessman who sits on a number of public company boards and specializes in executive management services, including corporate development, investor relations, financial reporting, company filings, budgeting and overseeing corporate governance, while achieving company objectives and maintaining internal cost controls.
Jan 30, 2020 04:19 pm ET
EGF Theramed Announces Change of Directors and New CEO
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2020) - EGF Theramed Health Corp. (CSE: TMED) has appointed David Bentil and Jatinder Dhaliwal to the board of EGF Theramed Health Corp. Mr. Bentil will assume the role of CEO and Mr. Dhaliwal will assume the role of director.
Nov 27, 2019 11:57 am ET
IIROC Trade Resumption - TMED
VANCOUVER, Nov. 27, 2019 /CNW/ - Trading resumes in:
Nov 25, 2019 08:00 am ET
EGF Theramed Corporate Update
VANCOUVER, BC / ACCESSWIRE / November 25, 2019 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF) (the "Company)
Nov 04, 2019 07:23 am ET
IIROC Trading Halt - TMED
VANCOUVER, Nov. 4, 2019 /CNW/ - The following issues have been halted by IIROC:
Oct 25, 2019 11:11 am ET
IIROC Trade Resumption - TMED
VANCOUVER, Oct. 25, 2019 /CNW/ - Trading resumes in:
Oct 24, 2019 04:19 pm ET
EGF Theramed Comments on Trading Halt and Confirms Share Consolidation and Trading on a Post Consolidated Basis
VANCOUVER, BC / ACCESSWIRE / October 24, 2019 / EGF THERAMED HEALTH CORP. (CSE: TMED, OTCQB: EVAHF or EVAHD (for a temporary basis)) (the "Company")
Oct 24, 2019 10:24 am ET
IIROC Trading Halt - TMED
VANCOUVER, Oct. 24, 2019 /CNW/ - The following issues have been halted by IIROC:
Oct 18, 2019 08:45 pm ET
Theramed Announces Receipt of New ISIN, CUSIP for EGF Theramed Health Corp and Consolidation
VANCOUVER, BC, ACCESSWIRE / October 18, 2019 / THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF) (the "Company") is pleased to announce that it has received a new ISIN and CUSIP for its new operating name of EGF Theramed Health Corp. The new ISIN is CA2684691033 and the new CUSIP is 268469103. In addition to the name change the company shall be undergoing a share consolidation of its issued and outstanding common shares on a one hundred (100) old to one (1) new basis. No fractional common shares will be issued pursuant to the Consolidation. All Fractional interests of less
Oct 04, 2019 09:20 pm ET
Theramed Announces Modification of Operating Name to EGF Theramed Health Corp.
VANCOUVER, BC / ACCESSWIRE / October 4, 2019, / THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF) (the "Company") is pleased to announce that it has passed a resolution to change its operating name to EGF Theramed Health Corp.
Sep 17, 2019 03:27 pm ET
Theramed Provides Operational Update for Nevada Lab
VANCOUVER, BC / ACCESSWIRE / September 17, 2019 / THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF) (the "Company") is pleased to announce that it has received final sign off on its operational permits for its Nevada hemp extraction lab and has completed commissioning of its Vitalis CO2 hemp extraction system.
Sep 05, 2019 02:35 pm ET
Theramed Announces Launch of Development Initiative for Asia Pacific Region to be Named EGF-Theramed Health
VANCOUVER, BC / ACCESSWIRE / September 5, 2019 / Theramed Health Corporation (CSE:TMED, OTCQB:EVAHF) (the “Company”) is pleased to announce the signing of a proposed joint venture agreement with an agent to develop the Asia Pacific market from the Hong Kong SAR (Special Administration Region) for the Company’s licensed cardio-metabolic health system and any developed products under the trade name EGF-Theramed Health.
Aug 12, 2019 08:00 am ET
Theramed Announces Closing of $350,000 of Senior Convertible Notes to Fund Extraction Operations
VANCOUVER, BC / ACCESSWIRE / August 12, 2019 / Theramed Health Corporation (CSE:TMED)(OTCQB:EVAHF) (the “Company”) is pleased to announce it has closed on a senior convertible debenture financing of $350,000 for working capital, and to fund operations of its extraction facility.
Jun 19, 2019 03:55 pm ET
Theramed Health Corporation Announces Closing of 2nd Tranche of Private Placement
VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / Theramed Health Corporation (CSE: TMED, OTCQB: EVAHF) (the "Company") is pleased to announce that it has closed on a second tranche totaling $107,500 in subscriptions and $8,400 in settlement of legal fees of the previously announced a non-brokered private placement of up to one million Canadian dollars for units at $0.10 comprised of one common share and one full warrant exercisable at $0.15 into one common share for a period of three years from the closing. The warrants will be subject to an acceleration
May 28, 2019 08:00 am ET
Theramed Scientific Advisor and Resident Cannabinologist to Co-Host Panels at Major Extraction Conference
VANCOUVER, BC / ACCESSWIRE / May 28, 2019 / THERAMED HEALTH CORP. (CSE: TMED, OTCQB: EVAHF) (the "Company") is pleased to have one of their scientific advisors co-hosting various panels in one of the leading international extraction and analytical testing conferences.
May 23, 2019 09:40 pm ET
Theramed Comments on Recent Trading Activity
VANCOUVER, BC / ACCESSWIRE / May 23, 2019 / THERAMED HEALTH CORP. (CSE: TMED, OTCQB: EVAHF) (the "Company") is making the following statements regarding certain market activity surrounding the company's common shares.
May 22, 2019 05:50 pm ET
Theramed Provides Update on New Sales Channel for Nevada Facility
VANCOUVER, BC / ACCESSWIRE / May 22, 2019 / THERAMED HEALTH CORP. (CSE: TMED, OTCQB: EVAHF) (the "Company") is pleased to announce interest from a large "C-Store" fulfillment agent that can provide product placement for the Company's Hemp based CBD product lines in an estimated 24,000 locations.
May 22, 2019 08:00 am ET
Theramed Announces New Product Launch and Sales Orders for Nevada Facility, and Financing Update
VANCOUVER, BC / ACCESSWIRE / May 22, 2019 / THERAMED HEALTH CORP. (CSE: TMED, OTCQB: EVAHF) (the "Company") is pleased to announce a first round of sales for its new product line from its flagship Hemp processing facility in Las Vegas, Nevada.
May 21, 2019 08:45 am ET
Theramed Health Corporation Announces Closing of First Tranche of Private Placement, and Corporate Update
VANCOUVER, BC / ACCESSWIRE / May 21, 2019 / Theramed Health Corporation (CSE: TMED, OTCQB: EVAHF) (the "Company") is pleased to announce that effective today it has closed on $505,000 of gross proceeds as a first tranche on a non-brokered private placement of up to one million Canadian dollars for units at $0.10 comprised of one common share and one full warrant exercisable at $0.15 into one common share for a period of three years from the closing. The warrants will be subject to an acceleration clause where in the event the share price of the compa
May 07, 2019 10:28 pm ET
EVITRADE Announces Rebranding and Name Change to THERAMED Health Corporation
VANCOUVER, BC / ACCESSWIRE / Tuesday, May 7, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the 'Company') is pleased to announce that on May 1, 2019 it changed its name from 'EVITRADE Health Systems Corp.' to 'THERAMED HEALTH CORPORATION' with the British Columbia corporate registry, and it has rebranded itself under its new name and will trade under the new symbol 'TMED' expected to be effective May 8, 2019.